Toggle navigation
HOME
ABOUT US
KNOW US
OUR EVOLUTION
CSR INITIATIVES
RUBICON CONSUMER HEALTHCARE
LEADERSHIP TEAM
OPERATIONS
OVERVIEW
R&D
MANUFACTURING
PRODUCTS
TECHNOLOGIES
INVESTORS
CAREERS
PARTNERING
BUSINESS DEVELOPMENT
CONTACT US
Connect with us!
Like us!
Follow us!
Financial Statements
COMPANY
Rubicon Research Limited Standalone
Rubicon Research SFS Financial Year 2022
Rubicon Research SFS Financial Year 2023
Rubicon Research SFS Financial Year 2024
Rubicon Research SFS Financial Year 2025
Rubicon Research SFS for the Quarter ended June 30, 2024
Rubicon Research SFS for the Quarter ended June 30, 2025
Rubicon Research Limited Consolidated
RRPL Consolidated Financial Statements FY 22
RRPL Consolidated Financial Statements FY 23
RRPL Consolidated Financial Statements FY 24
RRL Consolidated Financial Statements FY 25
RRL Consolidated Financial Statements for the Quarter ended June 30, 2024
RRL Consolidated Financial Statements for the Quarter ended June 30, 2025
SUBSIDIARIES
AdvaGen Pharma Ltd.
AdvaGen Pharma Ltd Financial Year 2022-2024
AdvaGen Pharma Ltd Financial Year 2025, Quarters ended June 30, 2024, and June 30, 2025
Rubicon Research Canada
RRCL Financial Statement FY 22
RRCL Financial Statement FY 23
RRCL Financial Statement FY 24
RRCL Financial Statement FY 25
RRCL Financial Statement for the Quarter ended June 30, 2024
RRCL Financial Statement for the Quarter ended June 30, 2025
Rubicon Consumer Healthcare
RCHPL Financial Statement FY 22
RCHPL Financial Statement FY 23
RCHPL Financial Statement FY 24
RCHPL Financial Statement FY 25
RCHPL Financial Statement for the Quarter ended June 30, 2024
RCHPL Financial Statement for the Quarter ended June 30, 2025